Covestor’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-118
Closed -$1K 2208
2024
Q1
$1K Sell
118
-21
-15% -$125 ﹤0.01% 1892
2023
Q4
$1K Buy
139
+133
+2,217% +$922 ﹤0.01% 1915
2023
Q3
$0 Sell
6
-18
-75% -$150 ﹤0.01% 2078
2023
Q2
$0 Buy
24
+15
+167% +$144 ﹤0.01% 2097
2023
Q1
$0 Buy
+9
New +$115 ﹤0.01% 1979
2022
Q1
Sell
-14
Closed 2070
2021
Q4
$0 Buy
+14
New +$386 ﹤0.01% 2092

Other funds holding ANGO

Covestor's ANGO Position: Q2 2024 in Review

Covestor sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 118 shares — an estimated $1K sold.

Covestor first reported a position in ANGO in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q1 2024. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Covestor reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • Covestor sold 118 AngioDynamics shares in Q2 2024, an estimated $1K.
  • Covestor first reported a position in AngioDynamics in Q4 2021 and held it in 6 quarters.
  • Covestor's AngioDynamics position peaked at $1K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Covestor's 13F filing for Q2 2024, filed 9 Aug 2024.